Cni Research Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Cni Research şirketinin toplam hissedar öz sermayesi ₹169.7M ve toplam borcu ₹0.0 olup, bu da borç-öz sermaye oranını 0% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla ₹169.8M ve ₹122.0K dir.

Anahtar bilgiler

Borç/özkaynak oranı

₹0

Borç

Faiz karşılama oranı	n/a
Nakit	₹10.56m
Eşitlik	₹169.71m
Toplam yükümlülükler	₹122.00k
Toplam varlıklar	₹169.83m

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 512018 'nin kısa vadeli varlıkları ( ₹10.7M ) kısa vadeli yükümlülüklerini ( ₹122.0K ) aşıyor.

Uzun Vadeli Yükümlülükler: 512018 un uzun vadeli yükümlülüğü bulunmamaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 512018 borçsuzdur.

Borcun Azaltılması: 512018 son 5 yıldır borcu bulunmamaktadır.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: 512018 şirketinin mevcut serbest nakit akışına göre bir yıldan az nakit akışı süresi bulunmaktadır.

Tahmini Nakit Akışı: 512018 un, serbest nakit akışı her yıl % 58.1 oranında tarihi oranda azalmaya devam ederse bir yıldan az nakit akışı süresi vardır

Cni Research Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

Second quarter 2025 earnings released: ₹0.28 loss per share (vs ₹0.014 profit in 2Q 2024)

Cni Research Limited to Report Q2, 2025 Results on Nov 08, 2024

First quarter 2025 earnings released: EPS: ₹0.02 (vs ₹0.05 in 1Q 2024)

Cni Research Limited to Report Q1, 2025 Results on Aug 06, 2024

Cni Research Limited announced that it expects to receive INR 6.6 billion in funding

Cni Research Limited, Annual General Meeting, Jun 26, 2024

New minor risk - Earnings quality

Full year 2024 earnings released: EPS: ₹0.07 (vs ₹0.075 loss in FY 2023)

Third quarter 2024 earnings released: ₹0.02 loss per share (vs ₹0.05 profit in 3Q 2023)

Cni Research Limited to Report Q3, 2024 Results on Feb 07, 2024

Second quarter 2024 earnings released: EPS: ₹0.01 (vs ₹0.02 in 2Q 2023)

First quarter 2024 earnings released: EPS: ₹0.05 (vs ₹0.02 in 1Q 2023)

Cni Research Limited, Annual General Meeting, Sep 29, 2023

Cni Research Limited to Report Q1, 2024 Results on Aug 11, 2023

Full year 2023 earnings released: ₹0.07 loss per share (vs ₹0.15 profit in FY 2022)

Cni Research Limited to Report Q4, 2023 Results on May 25, 2023

Investor sentiment improves as stock rises 40%

Investor sentiment deteriorates as stock falls 16%

Third quarter 2023 earnings released: EPS: ₹0.05 (vs ₹0.04 in 3Q 2022)

Cni Research Limited to Report Q3, 2023 Results on Feb 08, 2023

Investor sentiment improved over the past week

Insufficient new directors

Investor sentiment improved over the past week

Second quarter 2023 earnings released: EPS: ₹0.02 (vs ₹0.07 in 2Q 2022)

Investor sentiment improved over the past week

Cni Research Limited, Annual General Meeting, Sep 30, 2022

Cni Research Limited to Report Fiscal Year 2022 Results on Aug 24, 2022

Cni Research Limited to Report Q1, 2023 Results on Jul 27, 2022

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Cni Research Limited to Report Q4, 2022 Results on May 28, 2022

Insufficient new directors

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment deteriorated over the past week

Cni Research Limited to Report Q3, 2022 Results on Feb 11, 2022

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS ₹0.07 (vs ₹0.27 loss in 2Q 2021)

First quarter 2022 earnings released: EPS ₹0.013 (vs ₹0.001 loss in 1Q 2021)

Full year 2021 earnings released: ₹0.31 loss per share (vs ₹0.021 loss in FY 2020)

New 90-day low: ₹1.50

Third quarter 2021 earnings released: ₹0.04 loss per share (vs ₹0.006 profit in 3Q 2020)

New 90-day low: ₹1.54

Cni Research Limited to Report Q3, 2021 Results on Feb 11, 2021

New 90-day high: ₹1.90

Cni Research Limited, Annual General Meeting, Dec 26, 2020

New 90-day high: ₹1.60

Cni Research Limited to Report Q1, 2021 Results on Aug 27, 2020

New 90-day low - ₹1.37

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Nakit Pist Analizi

Sağlıklı şirketleri keşfedin